Mutational landscape of atherosclerotic plaques reveals large clonal cell populations
The notion of clonal cell populations in human atherosclerosis has been suggested but not demonstrated. Somatic mutations are used to define cellular clones in tumors. Here, we characterized the mutational landscape of human carotid plaques through whole-exome sequencing to explore the presence of clonal cell populations. Somatic mutations were identified in 12 of 13 investigated plaques, while no mutations were detected in 11 non-atherosclerotic arteries. Mutated clones often constituted over 10% of the sample cell population, with genes related to the contractile apparatus enriched for mutations. In carriers of clonal hematopoiesis of indeterminate potential (CHIP), hematopoietic clones had infiltrated the plaque tissue and constituted substantial fractions of the plaque cell population alongside locally expanded clones. Our findings establish somatic mutations as a common feature of human atherosclerosis and demonstrate the existence of mutated clones expanding locally, as well as CHIP clones invading from the circulation. While our data do not support plaque monoclonality, we observed a pattern suggesting the coexistence of multiple mutated clones of considerable size spanning different regions of plaques. Mutated clones are likely to be relevant to disease development, and somatic mutations will serve as a convenient tool to uncover novel pathological processes of atherosclerosis in future studies.
Authors
- Lars Melholt Rasmussen (ORCID: https://orcid.org/0000-0001-5795-4794)
- Lasse Bach Steffensen (ORCID: https://orcid.org/0000-0001-6353-4227)
- Stephanie Kavan (ORCID: https://orcid.org/0000-0001-5272-2118)
- Lars van Brakel Andersen
- Ljubica Matic (ORCID: https://orcid.org/0000-0002-7294-9667)
- Jes S. Lindholt (ORCID: https://orcid.org/0000-0001-9536-4488)
- Maja Dembić (ORCID: https://orcid.org/0000-0003-2505-6863)
- Martin Bjerregård Pedersen (ORCID: https://orcid.org/0000-0001-8261-2374)
- Kim Christian Houlind (ORCID: https://orcid.org/0000-0002-1600-4415)
- Ulf Hedin (ORCID: https://orcid.org/0000-0001-9212-3945)
- Lars Peter Riber (ORCID: https://orcid.org/0000-0001-6898-2715)
- Otto Bergman (ORCID: https://orcid.org/0000-0003-4323-8150)
- Pia Søndergaard Jensen
- Martin J. Larsen (ORCID: https://orcid.org/0000-0003-4107-8771)
- Mads Thomassen (ORCID: https://orcid.org/0000-0003-0078-1217)
- Steffen Møller Bøttger
Institutions
- Human Genome Sciences (United States) (US)
- Karolinska University Hospital (SE)
- University of Southern Denmark (DK)
- Odense University Hospital (DK)
- Karolinska Institutet (SE)
- Pharmacology Research Institute (US)
- Kolding Hospital (DK)
- Centre for Individualised Infection Medicine (DE)
Publication Details
- Journal
- JCI Insight
- Published
- 2025-04-08
- DOI
- https://doi.org/10.1172/jci.insight.188281
- Citations
- 3
- Primary Topic
- Single-cell and spatial transcriptomics
- Type
- article
- Field-Weighted Citation Impact
- 2.42
Funders
- Novo Nordisk
- Odense Universitetshospital
- Novo Nordisk Fonden